Michal Eid: "Precision therapy is suitable for a third of patients in oncology and the number is increasing."
Precision therapy is appropriate for one-third of patients in oncology and the number is increasing, data show. This is one of the arguments why the Centre for Precision Medicine started operating at the University Hospital Brno in May. Dr. Michal Eid from the Internal Hematology and Oncology Clinic of the University Hospital Brno and the Faculty of Medicine of Masaryk University, as the chairman of its Molecular Oncology Indication Committee, is fundamentally involved in the indication of precision treatment for oncology patients.
